MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Effects on voice sound level and brain connectivity after HiCommunication: a novel speech and communication treatment for Parkinson’s disease

H. Steurer, F. Albrecht, A. Razi, J. Körner Gustafsson, E. Franzén, E. Schalling (Stockholm, Sweden)

Meeting: 2023 International Congress

Abstract Number: 125

Keywords: Dysarthria, Interventions, Parkinson’s

Category: Parkinson’s Disease: Clinical Trials

Objective: This study aimed to evaluate the clinical relevance of effects on voice sound level (Lv) as well as brain connectivity using resting-state functional MRI (rsfMRI) following a novel speech and communication treatment for Parkinson’s disease (PD).

Background: The HiCommunication program for speech and communication in PD is based on principles driving neuroplasticity and has shown high compliance and acceptability [1] as well as positive results at a group level of the primary outcome measure Lv [2].

Method: Participants with PD (n=95) were recruited within a randomized controlled trial [3] and allocated to intervention with either HiCommunication or HiBalance (targeting balance and gait). Speech recordings and rsfMRI were performed pre and post intervention. Clopper Pearson exact 95% confidence intervals for the proportion of participants with a clinically relevant increase in Lv were calculated. Linear regression was used to test if Lv at baseline significantly predicted the change following HiCommunication. Complete rsfMRI data were available from 28 participants in the HiCommunication group. Spectral dynamic causal modeling [4] and the parametric empirical Bayes [5] methods were applied to describe effective connectivity changes in a speech related network [6].

Results: The percentage of participants with a clinically relevant increase in Lv after HiCommunication was 59%, CI [41%, 75%] and after HiBalance 13%, CI [4%, 28%]. It was found that Lv at baseline significantly predicted the change in Lv after HiCommunication (β = -0.332 p = 0.009). Pre HiCommunication an inhibitory effective connectivity from the right to the left supplementary motor area (SMA) was found. Further, the left SMA to the left paracentral gyrus showed inhibitory connectivity. Excitatory effective self-connectivity was found in the left SMA and paracentral gyrus. Post HiCommunication, the inhibitory effective connectivity from the right to the left SMA decreased and was the only effective connectivity found.

Conclusion: The results from this study suggest clinically relevant effects on Lv after HiCommunication. Notably, participants with a lower Lv at baseline showed a larger change in Lv following the intervention. Furthermore, resting-state connectivity was altered after the intervention. These changes could be a result of underlying compensatory effects but need further investigation.

References: [1] E. Schalling, H. Winkler, and E. Franzén, “HiCommunication as a novel speech and communication treatment for Parkinson’s disease: A feasibility study,” Brain and behavior, pp. e02150-e02150, 2021.
[2] M. Freidle et al., “Behavioural and neuroplastic effects of a double-blind randomised controlled balance exercise trial in people with Parkinson’s disease,” NPJ Parkinson’s Disease, vol. 8, no. 1, pp. 12-12, 2022.
[3] E. Franzén et al., “The EXPANd trial: effects of exercise and exploring neuroplastic changes in people with Parkinson’s disease: a study protocol for a double-blinded randomized controlled trial,” (in eng), BMC Neurol, vol. 19, no. 1, p. 280, Nov 12 2019.
[4] K. J. Friston, J. Kahan, B. Biswal, and A. Razi, “A DCM for resting state fMRI,” NeuroImage (Orlando, Fla.), vol. 94, no. 100, pp. 396-407, 2014.
[5] K. J. Friston et al., “Bayesian model reduction and empirical Bayes for group (DCM) studies,” NeuroImage (Orlando, Fla.), vol. 128, pp. 413-431, 2016.
[6] A. Baumann et al., “Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease,” Neurorehabilitation and neural repair, vol. 32, no. 12, pp. 1055-1066, 2018.

To cite this abstract in AMA style:

H. Steurer, F. Albrecht, A. Razi, J. Körner Gustafsson, E. Franzén, E. Schalling. Effects on voice sound level and brain connectivity after HiCommunication: a novel speech and communication treatment for Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/effects-on-voice-sound-level-and-brain-connectivity-after-hicommunication-a-novel-speech-and-communication-treatment-for-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/effects-on-voice-sound-level-and-brain-connectivity-after-hicommunication-a-novel-speech-and-communication-treatment-for-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley